Achaogen

Achaogen EBITDA per Share

Delisted

The EBITDA per Share of Achaogen (AKAOQ) as of Oct 10, 2026 is -3.77 USD. In the previous year, EBITDA per Share was -2.97 USD — a change of 26.96% (lower).

EBITDA per Share

-3.77USD

YoY

26.96%

Last updated:

EBITDA per Share of Achaogen is 2018 -3.77 USD. EBITDA per Share of Achaogen was 2017 -2.97 USD. It decreases by 26.96% lower compared to the previous year.

The Achaogen EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2014
-1.39 USD
Jan 1, 2015
-1.87 USD
Jan 1, 2016
-3.47 USD
Jan 1, 2017
-2.97 USD
Jan 1, 2018
-3.77 USD
The Achaogen EBITDA per Share history
YEAREBITDA per ShareYoY
-3.77USD+26.96%
-2.97USD-14.44%
-3.47USD+85.71%
-1.87USD+34.30%
-1.39USD—
Access this data via the Eulerpool API
Get Free API Key

Achaogen Stock analysis

What does Achaogen do? Achaogen Inc is an innovative biotechnology company specializing in the development of antibiotics for the treatment of life-threatening infectious diseases. The company's business model is based on research and development of new antibiotics, aiming to improve medical care for patients with infections. Achaogen was founded in 2002 by a team of researchers and professionals in the biotechnology industry and has developed several products for the treatment of diseases such as pneumonia, urinary tract infections, and bloodstream infections. The company's main divisions include Plazomicin, Zemdri, and C-Scape, which are antibiotics targeting different types of infections. Achaogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Achaogen stock

EBITDA per Share of Achaogen is -3.77 USD in 2018.

EBITDA per Share of Achaogen changed from -2.97 USD to -3.77 USD, representing a 26.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Achaogen since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Achaogen

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Achaogen